New-News

Latest News

News

News

A recent published study by Professor Robert Bucki and colleagues has shown that CSA-131 has broad spectrum antifungal activity and

Colistin is the last agent used to combat bacteria that are resistant to the strongest antibiotics. Colistin has remained the

A recent published study by Professor Jordi Vila and his colleagues at the University of Barcelona, Spain has found that

Contact us

Lets Get in Touch!

Follow now

mynewform

Basic contact form

N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.